Semaglutide, FITC labeled

Semaglutide, FITC labeled

• Alternative Name: AHPN
• UNSPSC Description: Semaglutide, FITC labeled is a FITC labeled Semaglutide. Semaglutide, a long-acting GLP-1 alogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide has the potential for type 2 diabetes treatment[1].
• Target Antigen: GCGR
• Type: Dye Reagents
• Related Pathways: GPCR/G Protein
• Field of Research: Metabolic Disease
• Assay Protocol: https://www.medchemexpress.com/semaglutide-fitc-labeled.html
• Purity: 95.51
• Solubility: DMSO : 6.67 mg/mL (ultrasonic)
• Smiles: O=C(NC(C)(C)C(N[C@@H](CCC(O)=O)C(NCC(N[C@@H]([C@H](O)C)C(N[C@H](C(N[C@@H]([C@H](O)C)C(N[C@@H](CO)C(N[C@H](C(N[C@@H](C(C)C)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@H](C(N[C@@H](CC(C)C)C(N[C@@H](CCC(O)=O)C(NCC(N[C@@H](CCC(N)=O)C(N[C@H](C(N[C@H](C(N[C@@H](CCCCNC(COCCOCCNC(COCCOCCNC(CCC(C(O)=O)NC(CCCCCCCCCCCCCCCCC(O)=O)=O)=O)=O)=O)C(N[C@@H](CCC(O)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC(C)C)C(N[C@@H](C(C)C)C(N[C@@H](CCCNC(N)=N)C(NCC(N[C@@H](CCCNC(N)=N)C(NCC(O)=O)=O)=O)=O)=O)=O)=O)CC1=CNC2=C1C=CC=C2)=O)C)=O)[C@@H](C)CC)=O)CC3=CC=CC=C3)=O)=O)=O)C)=O)C)=O)=O)=O)=O)=O)CC4=CC=C(O)C=C4)=O)=O)=O)=O)CC(O)=O)=O)=O)=O)CC5=CC=CC=C5)=O)=O)=O)=O)[C@@H](NC(NC(C=C6)=CC7=C6C8(OC7=O)C9=C(C=C(O)C=C9)CC%10=CC(O)=CC=C%108)=S)CC%11=CN=CN%11
• Molecular Weight: 4500.99
• References & Citations: [1]Marso SP, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016 Nov 10;375(19):1834-1844.
• Shipping Conditions: Blue Ice
• Storage Conditions: -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
• Clinical Information: No Development Reported